Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 19, 1998

View Archived Issues

New therapeutic tetrahydrofuran derivatives from Janssen

Cantab and Chemo-Sero to develop chickenpox and shingles vaccines

More dopaminergic agents in the pipeline at Neurogen

Novel CNS agents disclosed by HMR

New agents for cancer discovered at Zeneca

Vertex researchers report 3-D structure of hepatitis C enzyme

New antimalarial agent submitted to extensive clinical testing

Elan and Novartis to develop new formulation of Novartis drug

Clues into the molecular genetics of aging revealed

Artelinic acid: an attractive candidate for development as an antimalarial agent

Preclinical evaluation of leishmaniasis Rx reported

Interim Maxamine phase I data reported

Thienopyridine derivatives for arthritis, osteoporosis from Takeda

Merck & Co. claims carbapenems active against methicillin-resistant staphylococci

Peptide HIV protease inhibitors claimed by Merck & Co.

Novartis reveals agents for atherosclerosis and chronic inflammation

Lilly reports new benzothiophenes for gynecological and other disorders

Merck subsidiary and Autogen collaborate on obesity research

Lilly discloses novel compounds for influenza

Abbott again extends drug discovery collaboration with ArQule

IGG announces name change

Alza and Janssen E-TRANS pain product collaboration unveiled

Provir set to enter final stage of development for AIDS-related diarrhea

Raloxifene launched in U.S.

Virus Research Institute licenses novel immunotherapeutic delivery system

Cardizem Monovial now available in U.S.

Ground-breaking collaboration in MRI technology announced

Daiichi and Sumitomo to copromote antiallergic drug in Japan

Preclinical and clinical studies presented for RS-8359

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...